The Cephalon-backed stem cell therapy developer had been listed in Australia since 2004, and also counts Celgene as a shareholder.

The Sanofi-backed gene therapy company floated below its $15 to $17 range, but its shares have since risen to $17.50.

Biopharmaceutical company Wave Life Sciences has gone public at the middle of its range just nine months after closing its $18m SNBL-led series A round.

Rocket Internet-backed meal delivery service HelloFresh hoped to raise around $332m from an initial public offering.

Fidelity-backed biopharmaceutical company Kura floated on Nasdaq yesterday and will use proceeds to fund clinical trials.

State-owned debt management firm China Huarong Asset Management raises $2.3bn in its IPO, falling short of its $3bn target.

The classified listings website, spun out of eBay, is seeking a flotation on Chinese stock exchange National Equities Exchange and Quotations.

Vipshop-backed online fashion retailer Showroomprive floated below its range, selling individual shares at $2.25 below target.

The memory product manufacturer had raised more than $85m of debt and equity from backers including Applied Materials and Altera.

The cardiovascular drug developer, which had raised $94m from investors including Sanofi, priced its initial public offering considerably below the range set last week.